The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma

OBJECTIVE: To examine how observed medication nonadherence to 2 second-line, oral anticancer medications (axitinib and everolimus) affects progression-free survival (PFS) among patients with renal cell carcinoma. METHODS: We used an adherence–exposure–outcome model to simulate the impact of adherenc...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Manag Res
Auteurs principaux: Shafrin, Jason, Sullivan, Jeffrey, Chou, Jacquelyn W, Neely, Michael N, Doan, Justin F, Maclean, J Ross
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2017
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5713701/
https://ncbi.nlm.nih.gov/pubmed/29238223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S148199
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires